Debiopharm Further Explores the Potential of its Potent, Highly Selective WEE1 Inhibitor Debio 0123 In Phase 1 Cancer Study

Dose escalation, monotherapy trial launched to access the safety and preliminary anti-tumor activity of Debio 0123 in the treatment of advanced solid tumors Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today the first patient treated in the newly launched open-label, phase I study evaluating Debio 0123, an oral, potent and highly selective WEE1 inhibitor, as monotherapy […]

thaipr.net

16 ธ.ค. 64

Australian Open and Infosys extend Digital Innovation Partnership until 2026

The extended collaboration with Tennis Australia will introduce enhanced broadcast match statistics and new initiatives to make tennis more accessible for all, while continuing to develop innovative digital stakeholder experiences Infosys(NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced an extension of its digital innovation partnership with […]

thaipr.net

16 ธ.ค. 64
1 2,313 2,314 2,315 2,316 2,317 3,074